P

    Phibro Animal Health Corporation (PAHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $37.74
    +0.07 (+0.19%)

    Market Cap: $1.53B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +4.99%
    Streak
    11 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.79
    Range$0.79 - $0.79
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.81+2.5%
    60d ago$0.81+2.5%
    30d ago$0.81+2.5%
    7d ago$0.81+2.5%
    Current$0.79
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    Period ending Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-$0.79---
    Jun 26
    Reported Aug 26
    		$0.85$0.72+18.06%Beat+49.1%
    Mar 26
    Reported May 6
    		$0.76$0.71+7.04%Beat+20.6%
    Dec 25
    Reported Feb 4
    		$0.87$0.67+29.85%Beat+61.1%
    Sep 25
    Reported Nov 5
    		$0.73$0.59+23.73%Beat+108.6%
    Jun 25
    Reported Aug 27
    		$0.57$0.52+9.62%Beat+39.0%
    Mar 25
    Reported May 7
    		$0.63$0.52+21.15%Beat+103.2%
    Dec 24
    Reported Feb 5
    		$0.54$0.45+20.00%Beat+63.6%
    Sep 24
    Reported Nov 7
    		$0.35$0.25+40.00%Beat+150.0%
    Jun 24
    Reported Aug 28
    		$0.41$0.33+24.24%Beat+7.9%
    Mar 24
    Reported May 8
    		$0.31$0.29+6.90%Beat+6.9%
    Dec 23
    Reported Feb 7
    		$0.33$0.28+17.86%Beat-2.9%
    Sep 23
    Reported Nov 8
    		$0.14$0.23-39.13%Miss-33.3%
    Jun 23
    Reported Aug 30
    		$0.38$0.38+0.00%Beat+5.6%
    Mar 23
    Reported May 3
    		$0.29$0.34-14.71%Miss-12.1%
    Dec 22
    Reported Feb 8
    		$0.34$0.30+13.33%Beat-8.1%
    Sep 22
    Reported Nov 9
    		$0.21$0.27-22.22%Miss-16.0%
    Jun 22
    Reported Aug 24
    		$0.36$0.38-5.26%Miss+12.5%
    Mar 22
    Reported May 4
    		$0.33$0.35-5.71%Miss-2.9%
    Dec 21
    Reported Feb 9
    		$0.37$0.33+12.12%Beat+8.8%
    Sep 21
    Reported Nov 2
    		$0.25$0.29-13.79%Miss-7.4%
    Jun 21
    Reported Aug 25
    		$0.32$0.31+3.23%Beat+88.2%
    Mar 21
    Reported May 6
    		$0.34$0.32+6.25%Beat-10.5%
    Dec 20
    Reported Feb 3
    		$0.34$0.28+21.43%Beat+0.0%
    Sep 20
    Reported Nov 4
    		$0.27$0.23+17.39%Beat+42.1%
    Jun 20
    Reported Aug 26
    		$0.17$0.22-22.73%Miss-48.5%
    Mar 20
    Reported May 7
    		$0.38$0.34+11.76%Beat-2.6%
    Dec 19
    Reported Feb 3
    		$0.34$0.29+17.24%Beat-17.1%
    Sep 19
    Reported Nov 4
    		$0.19$0.24-20.83%Miss-51.3%
    Jun 19
    Reported Aug 27
    		$0.33$0.36-8.33%Miss-28.3%
    Mar 19
    Reported May 6
    		$0.39$0.43-9.30%Miss-18.7%
    Dec 18
    Reported Feb 6
    		$0.41$0.43-4.65%Miss+17.1%
    Sep 18
    Reported Nov 6
    		$0.39$0.41-4.88%Miss+2.6%
    Jun 18
    Reported Aug 27
    		$0.46$0.42+9.52%Beat+17.9%
    Mar 18
    Reported May 7
    		$0.48$0.44+9.09%Beat+14.3%
    Dec 17
    Reported Feb 5
    		$0.35$0.39-10.26%Miss+2.9%
    Sep 17
    Reported Nov 6
    		$0.38$0.37+2.70%Beat+5.6%
    Jun 17
    Reported Aug 30
    		$0.39$0.33+18.18%Beat-
    Mar 17
    Reported May 8
    		$0.42$0.34+23.53%Beat-
    Dec 16
    Reported Feb 6
    		$0.34$0.35-2.86%Miss-
    Sep 16
    Reported Nov 9
    		$0.36$0.36+0.00%Beat-

    Dividends

    Dividend Metrics

    Yield1.27%
    Annual/Share$0.48
    Payout Ratio20.44%
    Frequency4
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+0.00%
    5Y CAGR+0.00%
    View PAHC's full dividend history

    Key Metrics

    Valuation
    P/E Ratio11.76EV/EBITDA9.37x
    Price/FCF155.12xFCF Yield0.64%
    Profitability
    Profit Margin6.57%Operating Margin10.60%
    ROE29.70%ROIC11.57%
    Financial Health
    Debt/Equity2.03xInterest Coverage3.36x
    Current Ratio3.17xQuick Ratio1.26x
    Trading Statistics
    Beta0.46Avg Volume210.94K
    52-Week High$59.8352-Week Low$28.13

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$36.07
    SMA 20$35.41
    SMA 50$34.24
    SMA 200$41.82
    EMA 10$36.30
    EMA 20$35.70
    EMA 50$35.53
    EMA 200$38.35

    MACD

    Line: 0.66Signal: 0.42Hist: 0.25

    ADX

    ADX: 18.8+DI: 25.2-DI: 10.7

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down40.0
    PSAR$34.37

    Bollinger Bands

    Upper Band$37.75
    Lower Band$33.06
    %B Position1325%(Upper)
    Band Width1.00

    RSI (14-Day)

    Neutral
    66.4

    Momentum Oscillators

    Stoch %K66.0
    Stoch %D68.8
    Williams %R-27.1
    ROC (10d)9.0%
    Momentum3.11
    CCI (20d)141.5
    MFI (14d)73.5

    Volatility Measures

    ATR (14d)$1.55(4.1%)
    StdDev (20d)1.17
    Hist Vol28.7%(Moderate)

    Volume Flow

    VWAP$37.51
    OBV-1.8M
    AD Line-45.0M
    CMF (20d)-0.072

    Volume Metrics

    Avg Vol (20d)206.6K
    Vol Ratio1.5x(High)
    VWMA (20d)$35.77

    Pivot Points

    R3$41.05
    R2$39.85
    R1$38.76
    Pivot Point$37.56
    S1$36.47
    S2$35.27
    S3$34.18

    Advanced Oscillators

    TSI17.47
    Ultimate Osc47.1
    KST41.48

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$383.54M$373.91M$363.89M$378.70M$347.82M$309.26M$260.43M$273.16M$263.22M$249.94M$231.35M$255.05M
    Cost of Revenue$257.87M$241.25M$244.11M$268.69M$243.26M$207.39M$176.94M$186.01M$183.62M$171.33M$163.62M$178.38M
    Gross Profit$125.67M$132.66M$119.78M$110.01M$104.57M$101.87M$83.50M$87.15M$79.60M$78.62M$67.73M$76.67M
    Operating Expenses$81.02M$82.33M$68.52M$76.29M$71.05M$76.34M$65.80M$68.73M$59.68M$62.91M$68.45M$52.90M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$81.02M$82.33M$68.52M$76.29M$71.05M$76.34M$65.80M$68.73M$59.68M$62.91M$68.45M$52.90M
    Operating Income$44.65M$50.33M$51.26M$33.72M$33.52M$25.53M$17.70M$18.42M$19.92M$15.70M$-726,000$23.77M
    Interest Income$-10,431,000$-11,756,000$-12,059,000$-8,610,000$-9,355,000$-8,996,000$-7,641,000$-4,738,000$-4,575,000$-4,659,000$-4,564,000$0
    Interest Expense$12.34M$13.90M$14.99M$9.87M$3.83M$20.70M$8.08M$12.01M$7.00M$12.14M$11.25M$2.33M
    Income Before Tax$32.31M$36.42M$36.27M$23.85M$29.69M$4.84M$9.62M$6.41M$12.92M$3.56M$-11,979,000$21.44M
    Income Tax Expense$8.29M$8.97M$9.74M$6.62M$8.81M$1.65M$2.65M$5.66M$4.52M$2.29M$-3,964,000$9.94M
    Net Income$24.02M$27.46M$26.53M$17.22M$20.88M$3.19M$6.97M$752,000$8.40M$1.27M$-8,015,000$11.50M
    EBITDA$55.76M$61.64M$61.73M$45.44M$52.23M$25.91M$26.63M$20.61M$26.95M$17.39M$1.72M$34.73M
    EBIT$42.74M$48.18M$48.33M$32.46M$39.04M$13.83M$17.26M$11.15M$17.50M$8.22M$-7,415,000$25.94M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PAHC

    News

    Phibro Animal Health Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026

    Phibro Animal Health Corporation (NASDAQ: PAHC) filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, with the SEC on August 26, 2026. The report details key financial information including outstanding shares of Class A and Class B common stock, their market value held by non-affiliates, and outlines various risk factors that could impact the company's future performance. The company is classified as a large accelerated filer, and its proxy statement will be incorporated by reference within 120 days post fiscal year-end.

    Kalkine Media•8/26/26•
    Neutral

    Phibro Animal Health to report Q4 FY26 results on August 26

    Phibro Animal Health Corporation (NASDAQ: PAHC) is scheduled to announce its fourth quarter and fiscal year 2026 financial results after market close on Wednesday, August 26, 2026. Management will host a conference call and webcast on Thursday, August 27, 2026, at 9:00 am ET to discuss these results. Investors can access the live event via the company's investor relations website or by phone using Conference ID 3927884.

    scanx.trade•8/19/26•
    Neutral

    Phibro Animal Health CFO David Glenn Awarded 3,334 RSUs on August 6, 2026

    David Glenn, CFO of Phibro Animal Health Corp (NASDAQ: PAHC), was awarded 3,334 restricted stock units (RSUs) of Class A Common Stock on August 6, 2026. The filing for this acquisition was made on August 10, 2026, with the RSUs valued at $0.

    Kalkine Media•8/10/26•
    Neutral

    Phibro Animal Health (PAHC) awards 3,522 RSUs to Chief Operating Officer

    Phibro Animal Health Corp (PAHC) has granted 3,522 restricted stock units (RSUs) to its Chief Operating Officer, Larry Lee Miller. These RSUs, representing Class A Common Stock, will vest in three equal installments over three years, contingent on his continued employment. Following this grant, Miller directly holds 38,071 shares of Class A Common Stock, including the newly awarded RSUs.

    Stock Titan•8/10/26•
    Neutral

    Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources

    Phibro Animal Health (PAHC) awarded 1,547 restricted stock units (RSUs) to Lisa Ann Escudero, SVP of Human Resources, on August 6, 2026. These RSUs will vest in three equal installments on the first three anniversaries of August 1, 2026, contingent on her continued employment. Following this grant, Escudero directly holds 3,434 shares or share-equivalent RSUs of Class A Common Stock.

    Stock Titan•8/10/26•
    Neutral

    Frequently Asked Questions About PAHC

    What is PAHC's current dividend yield?
    Phibro Animal Health Corporation (PAHC) has a current dividend yield of 1.27%.
    Does PAHC pay dividends?
    Yes, Phibro Animal Health Corporation pays dividends with a current yield of 1.27%.
    What is PAHC's P/E ratio?
    Phibro Animal Health Corporation has a price-to-earnings (P/E) ratio of 11.76.
    What is PAHC's market cap?
    Phibro Animal Health Corporation (PAHC) has a market capitalization of $1.53B with a current stock price of $37.74.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In